The Urodynamic Equipment and Consumables Market was valued at US$ 173.7 million in 2019 and is anticipated to grow to US$ 283.8 million by 2027, reflecting a compound annual growth rate (CAGR) of 6.5% from 2020 to 2027.
The expansion of the Urodynamic Equipment and Consumables market can be primarily linked to several factors, including the rising incidence of chronic conditions that lead to kidney issues and the increasing prevalence of urinary incontinence. Nevertheless, the market may face challenges due to the availability of alternative treatments for urinary incontinence during the forecast period.
Urodynamic testing is a diagnostic procedure that assesses how effectively the bladder, sphincters, and urethra manage the storage and release of urine. Most urodynamic tests focus on the bladder's ability to retain urine and its capacity to fill gradually or completely. These tests can also determine if the bladder experiences involuntary contractions that result in urine leakage. Physicians may recommend urodynamic evaluations when symptoms indicate potential issues with the lower urinary tract.
Urinary incontinence is a significant concern linked to various medical conditions. It can range from mild or occasional leakage to severe, uncontrolled urination. This issue affects a considerable portion of the global population. Factors contributing to urinary incontinence include an aging population, rising obesity rates, and the increasing prevalence of chronic diseases such as cardiovascular disorders, prostate cancer, kidney diseases, multiple sclerosis, and diabetes, as well as stress-related incontinence stemming from lifestyle changes.
According to the National Institutes of Health (2016), there are 617 million individuals worldwide aged 65 and older. The elderly population is projected to grow substantially in Africa, followed by North America, Latin America & the Caribbean, and the Asia Pacific region. Furthermore, the National Association for Incontinence reports that approximately 200 million people globally suffer from urinary incontinence, highlighting the urgent need for urodynamic equipment and consumables.
The COVID-19 pandemic has posed a significant challenge worldwide, particularly in developing nations, as it has disrupted imports due to global trade interruptions. Additionally, the production and distribution of urodynamic equipment and consumables have been adversely affected by issues such as component manufacturing delays and supply chain disruptions. According to a report from the International Trade Centre (ITC), factory shutdowns in the EU, US, and China?accounting for 63% of global supply chain imports and 64% of exports?are projected to result in losses of USD 126 billion in 2020. Consequently, the market is expected to experience a decline in demand from end-users this year, with a gradual recovery anticipated in the following years as the effects of the pandemic subside.
The global Urodynamic Equipment and Consumables market is categorized by equipment type into cystometers, uroflowmetry devices, ambulatory urodynamic systems, electromyographs, video urodynamic systems, and urodynamic consumables. In 2019, the uroflowmetry equipment segment held the largest market share, driven by its widespread use in diagnosing urinary blockages, benign prostatic hypertrophy, bladder cancer, neurogenic bladder, bladder dysfunction, and prostate cancer. The ambulatory urodynamic systems segment is expected to exhibit the highest CAGR in the global Urodynamic Equipment and Consumables market throughout the forecast period.
Key sources for this report include the Centers for Disease Control and Prevention, the World Health Organization, the National Health Service, the Food and Drug Administration, the National Institutes of Health, the International Trade Centre, and the National Kidney Foundation.